Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Additions to Study Design

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Mar 23, 2024 8:05pm

220 Views

Post# 35949133

RE:RE:RE:RE:RE:Additions to Study Design

Would also explain why Roger is doing the small PPs every couple of months, I doubt they can keep going back to the same people if there was going to be a major delay. They must have some idea they are close and we just have to suffer these little price corrections until it all happens.

Longholder99 wrote: Does it make sense that if AA is in the crosshairs. Enrollment has stalled because after AA is acheived they can start charging money for treatments. Saving the bank account Would explain trial parameter changes as well. Just a thought.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions